Blowing the Whistle at the FDA, Jan 2001, exposing Dearborn and how OspA causes immunosuppression rather than, "was a vaccine."

01 Oct 2017


File List, RICO

1988 Steere says Lyme is like a B cell leukemia

Assoc Blogs-n-Webs:




Fungal Exosomes Inhibit Apoptosis

IDSA: "Vaccines serve the mfgs, not their victims"


BlumenthalAntiTrust Lawsuit

Exosomes, Blebs


CDC Admits Fraud, 2016
Dattwyler, 1988
Golightly, 1988
Dressler, 1994
BarbourFish, 1993
Dearborn, 1994

Pathogenic Fungi

Bush's warcrimes, Oct 2000








Lobbying for a hearing for referral to the USDOJ for a prosecution of the Lyme disease crimes.


5 –  “Defrauding the Govt,” Allen Steere & CDC officers Johnson and Barbour =

9 -- 1990 CDC case definition (No ELISA, Lyme has antigenic variation)

11 – Dearborn case definition (Steere shows he knows NeuroLyme wont test positive)

14 – “Assault” of Czech children with fake vaccine to see how serious would be the injuries

16 – Who was involved, including OspA vaccine trial administrators?

17 -- Appendix A:  I-RICO and “Color of Law” charges, II- Mayo’s ad, pg 20

21 -- Appendix B --  HLAs and TLRs, Autism vaccines;  (pg 24 = Shapiro, PBS)

26 – Thimerosal was put in vaccines to prevent LYMErix or fungal contamination

29 -- Appendix C - MB Pfeiffer in HuffPo 170109 “Holy Shit”, we screwed up over Dearborn

30-  What is OspA?

34 --  Hoof and Mouth Disease DNA in muscle biopsies in Chronic Fatiguing disease … and with reactivation of Epstein-Barr.  And oh, ho hum, Plum Island.



This RICO, Fraud, Pediatric “Assault” (with LYMErix), and “Color of Law” abuses case was already filed with the USDOJ in 2003.

Three years later, former DOJ prosecutor (now Senator) Richard Blumenthal sued for Anti-Trust under CT civil law when he was the Connecticut Attorney General. 

Previously, the FDA ordered SmithKline to voluntarily withdraw LYMErix or the FDA would order it off officially (ultimatum).  The withdrawal of this fungal toxin of a vaccine was announced on February 26, 2002 by SmithKline Beecham (now Glaxo-SmithKline).


Although the charges in this case are clear: Defrauding the Govt., RICO, and Color of Law, none of the non-profits or participated in attempting to get it prosecuted (except, Hartford, CT) and to date, still aren't.  Were the case prosecuted and the scandal exposed, there would be no need for these fake non-profits.  The author of this handbook was a member of ILADS when she blew the whistle at the FDA (010131) and when she wrote the, ILADS’ “Klempner ‘re-treatment study’ rebuttal (“if Dearborn is invalid, Klempner & the IDSA ‘Guidelines’ are invalid”), June, 2001.  

Despite all these obvious facts, has never mentioned how OspA alone causes "chronic Lyme," and never talks about the falsified case definition, because people would then ask, "What are you treating, if OspA alone causes the 'multi-system' disease of Chronic Lyme?" (Neither has IDSA answered the specific question as to what OspA actually is, and that’s the bigger complaint.)

"Additional uncertainty may arise if the vaccines are not completely protective; vaccinated patients with
 multisystem complaints characteristic of later presentations of Lyme disease may be difficult to distinguish from patients with vaccine failure."  - Crooks Schoen (Yale) and Persing (Mayo), 1995, US Patent 6, 045,804 admitting that LYMErix or OspA vaccination caused the same disease we know of as Chronic Lyme.
As you have just seen, the Lyme Cryme perpetrators have SAID: “You can’t tell Lyme and LYMErix disease apart because they are both post-septic shock syndrome.” “Multi-system” disease means post-septic shock syndrome.  “Overwhelming the immune system” is the same thing as post-septic shock syndrome.


What we want prosecuted is the falsification of the "case definition" of Lyme, intended to exclude neurologic Lyme cases in order to pass off a bogus fungal vaccine, OspA, or Pam3Cys. OspA caused the same immunosuppression disease that resulted in the variety show of diseases (also known as a "Great Imitator") that are outcomes Lyme- or Tick Bite Sepsis and are mainly caused by the secondary opportunistics (EBV, etc). One of the names for this condition is post-sepsis syndrome.  Post-sepsis syndrome is like AIDS but without the T cell virus.

The researchers looked for viruses like Epstein-Barr [EBV] and herpes simplex that are often dormant in healthy people but can reactivate in those with suppressed immune systems
.”- NIH, 2014.  This is a well-known phenomenon and is seen across diseases outcomes, such as transplant cases and Humira/Stelara users when they become too immunosuppressed from their medications. You hear and see warnings of reactivating latent EBV and EBV-induced cancer or leukemia/lymphoma.  ‘Same with the pediatric MMR.  The monograph warns against vaccinating immunosuppression children, because then those live viruses become reactivated.  (These facts are an “Occam’s Razor.”)


It is a criminal offense to request a grant from the federal government based on fraud.

The biggest such fraud instance was when Mark Klempner asked for a 4.7 million dollar grant -knowing the case definition was false and that spirochetes persist and were incurable with ceftriaxone due to being intracellular -, to assess "long term treatment outcomes:"

Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro.

Klempner also later said Lyme did not cause any cognitive impairment after proving there was a nerve and brain degrading enzyme in the cerebrospinal fluid of Lyme victims in 79% of us:


Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

Next, the Klempner “we found nerve and brain-degrading enzymes” report:


Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.

This is the falsified grant request and fake "study," was based on the falsified Dearborn case definition:

Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.


This ^^ Klempner "study" became the basis of the Infectious Diseases Society of America's (IDSA's) "Guidelines" on the diagnosis and treatment of Lyme disease.  Here we will show the case definition (diagnosis criteria) was falsified, and therefore there can be no “guidelines” on “treatment.”


Understanding that the OspA vaccines caused the same "multi-system" (Yale, Mayo Clinic, US patent, 6, 045, 804) disease we know of as "Chronic Lyme (CLD)" is essential to this case.  It turns out, CLD is a condition of chronic immune deficiency and is physiologically the same as AIDS or post-sepsis syndrome where the secondary opportunistic infections reactivated via immunosuppression, tissue and organ damage (brain, gut), are what's causing the ongoing illness.


If Lyme disease is incurable due to its being a post-sepsis syndrome with immune system-, organ- and tissue damage, a leaky blood brain barrier, leaky gut, and a multitude of fungal, bacterial and viral infections that cant be fought off due to what happens to the immune system in sepsis, then there is another charge is Color of Law where Government employees slandered and libeled us to deny us any kind of care.  Lyme disease has been one great big charade to which no "MD" or group of "MDs" has been competent.



Remember what the NIH said about sepsis and post-sepsis (in addition to all the other things they said, like OspA alone causes this outcome in Lyme victims):

NIH, Carolyn Beans:  Surviving Sepsis: Detection and Treatment Advances - Live Science

Preventing Secondary Infections

Some people who survive sepsis can develop secondary infections days or even months later. A research team that included Richard Hotchkiss, Jonathan Green and Gregory Storch of Washington University School of Medicine in St. Louis suspected that this is because sepsis might cause lasting damage to the immune system. To test this hypothesis, the scientists compared viral activation in people with sepsis, other critically ill people and healthy individuals. The researchers looked for viruses like Epstein-Barr and herpes simplex that are often dormant in healthy people but can reactivate in those with suppressed immune systems. [Sepsis Has Long-Term Impact for Older Adults, Study Finds]

Of the three study groups, people with sepsis had much higher levels of these viruses, suggesting reactivation due to compromised immune responses. Immune suppression could make it difficult to defend against the reactivated viruses as well as new infections like pneumonia. The team now plans to test whether immune-boosting drugs can prevent deaths in sepsis survivors.













Defrauding the Government with the falsified case definition: Allen Steere


923. 18 U.S.C. § 371—Conspiracy to Defraud the United States ...

 To conspire to defraud the United States means primarily to cheat the Government out of property or money, but it also means to interfere with or obstruct one of its lawful governmental functions by deceit, craft or trickery, or at least by means that are dishonest.


924. Defrauding the Government of Money or Property | USAM ...
 Defrauding the Government of Money or Property. Under 18 U.S.C. § 371 the act of defrauding the government of money or property may take many forms, including the inducement of payment. for services or supplies not provided or provided at inflated prices; for work for which the government is not responsible.



1994 CDC, “Dearborn”/Current- case definition says you need 5 of 10 IgG bands (arthritis only), after the non-HLA-linked-,  non-arthritis cases are screened out in the first step, the ELISA.  

That is, Chronic Neurologic Lyme cases, which are immunosuppression outcomes - like AIDS, where the opportunistics do most of the damage and are what keep you ill -, were left out at the first step, the ELISA, because this outcome was caused by injections of the fungal toxin OspA (the Lyme vaccines), too.


The Disease (fungal-toxic immunosuppression or post-sepsis syndrome)…is the Cryme (saying OspA was a “vaccine” when it caused the same toxic,  post-sepsis syndrome).

The Dearborn case definition was not a consensus. The average accuracy was 15%, as is shown in this booklet covering the Dearborn conference:

Where does the Dearborn proposal come from?  [Steere in Europe, 1992-1993]


J Infect Dis. 1994 Feb;169(2):313-8.
Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.   (Dressler F1, Ackermann R, Steere AC.)


The above graphic shows:

1) Allen Steere in the IgM ELISA arbitrarily raised the "noise" cutoff of 3 standard deviations to 5 std dev (3 is normally done) such that most Neurologic cases would be missed (arthritis cases produce lower IgM, for some reason).  

2) Steere in the IgG-falsification step, averaged the concentration of IgGs from the meningitis or neurologic Lyme (lower, like 1:400 dilution), with acrodermatitis (autoimmune, very high antibody concentration of about 1:25o0) and arthritis (1:800 dilution).  

This fraud deliberately excluded the sickest patients in the first step of the Dearborn "2-tiered" testing criteria for Lyme.  Note that it is strange that Steere felt he had to develop this new Dearborn panel in Europe, presumably where American Justice would have a hard time verifying the data.

Note this same report reveals an intended a later monopoly on testing for Lyme once the bogus OspA vaccines were on the market (you never test for a disease with the same antigens that are the vaccine antigens since you would not know if the antibodies are from the actual infection or from the vaccine antigens):


The above graphic shows:

3) Steere used high passage strains which lose plasmids and therefore potential antigens (meaning if you have those antibodies, they wont be detected); We’re not even sure if strain G39/40 bears OspA/B.

4) Steere used strain B31 which essentially does not have the European kinds of OspAs, and he assured no one would have antibodies against OspA and B in this Dearborn antibody panel for Western Blotting by leaving off the Pam3 or the tri-acyl or the lipid groups of these triacyl lipoproteins which cause antibodies.  The protein ends by themselves are not immunogenic (cause antibodies to be produced).

See full text here >>



WHO was involved with approving it anyway?  [Johnson, Barbour, Steere, McSweegan, etc]


^^^ This graphic is from pages 37 and 38 of the Dearborn booklet.


Barbour (ALDF, CDC)
McSweegan (ALDF, NIH employee)
Allen Steere, Arthur Weinstein, Russell Johnson (…
”CDC Lyme Disease Group,” ie., CDC employee Barbara Johnson, ALDF member, multi-patent owner with SmithKline…


The people named here are essentially the same cabal who own all the patents, is the, and who were on the FDA committees to approved their own bogus recombinant triacyl lipoproteins (fungal and immunosuppressive) as vaccines.  Steere, Schoen, etc., the [RICO].

The is the RICO “enterprise.”


More at:

“Another common issue concerns the element requiring a pattern of racketeering activity. The RICO Act itself defines the term pattern as two or more acts of racketeering activity within a 10-year period. However, the Supreme Court has weighed in on this issue as well. According to the Court, to qualify as a pattern, the criminal activities must be related and continuous. Relatedness will be established if the crimes have similar characteristics such as the same perpetrators, victims, and methods of commission. Continuity will be established if the crimes occurred over a substantial period of time. Some courts have interpreted this to mean at least one year.
The Previous, 1990, CDC case definition (No, ELISA, IgM counts):




This 1990 standard just says to perform repeated or sequential Western Blots to look for new IgM bands because that meant to Allen Steere that the bug “remains alive throughout the illness.”


Where does this 1990 case definition came from?  [Steere, 1986, says band 41 alone is fine]:

J Clin Invest. 1986 Oct;78(4):934-9.

Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Craft JE, Fischer DK, Shimamoto GT, Steere AC. (full text)

ABSTACT:  “Using immunoblots, we identified proteins of Borrelia burgdorferi bound by IgM and IgG antibodies during Lyme disease. In 12 patients with early disease alone, both the IgM and IgG responses were restricted primarily to a 41-kD antigen. This limited response disappeared within several months. In contrast, among six patients with prolonged illness, the IgM response to the 41-kD protein sometimes persisted for months to years, and late in the illness during arthritis, a new IgM response sometimes developed to a 34-kD component of the organism. The IgG response in these patients appeared in a characteristic sequential pattern over months to years to as many as 11 spirochetal antigens. The appearance of a new IgM response and the expansion of the IgG response late in the illness, and the lack of such responses in patients with early disease alone, suggest that B. burgdorferi remains alive throughout the illness.” !!!




The above graphic from the same 1986 report shows Allen Steere believed band 41 or the anti-flagellar antibody would have been good enough to detect, especially, early Lyme. 


This Borrelia burgdorferi-specific antibody testing, was later VALIDATED per the FDA rules on the Validation of a Bioanalytical Method, in U.S. patent 5, 618,533.  The testing was made SPECIFIC by coding for a section of flagellin that was SPECIFIC to burgdorferi (did not cross react with other flagellins.  It was made ACCURATE by detecting 17/18 known cases (known by a DNA method).  And it detects early late, neurologic, and arthritis Lyme.  The people who are the “inventors” of this patent, Yale’s Fikrig and Flavell, also own the LYMErix patent.   Because this testing could have been used to assess the outcome of LYMErix, but was not (the Dearborn falsified criteria were), and Fikrig and Flavell did not say anything or object to Dearborn or how the OspA vaccines were assessed, these two are likeliest to be the ones who “flip,” take a plea deal, and rat out the cabal.


But the current, Dearborn case definition, the one used to defraud the government out of grant money to say “people are not sick from Lyme” (Klempner) and to claim they had OspA “vaccines” (ImmuLyme and LYMErix) is this (5 of 10 IgG bands, and practically no IgM bands, when IgM bands are more associated with chronic, ongoing, neurologic spirochetal disease):

"It was recommended that an IgM immunoblot be considered positive if two of the following three bands are present: 24 kDa (OspC) * , 39 kDa (BmpA), and 41 kDa (Fla) (1). It was further recommended that an that IgG immunoblot be considered positive if five of the following 10 bands are present: 18 kDa, 21 kDa (OspC) *, 28 kDa, 30 kDa, 39 kDa (BmpA), 41 kDa (Fla), 45 kDa, 58 kDa (not GroEL), 66 kDa, and 93 kDa (2)."

1993 Steere showing positive cases are HLA-linked and neuroLyme is not.


When presenting this, you will be reading this out-loud, so it is LOUD AND CLEAR that neurologic Lyme cases "who never had arthritis" (and never will because they dont have the HLAs) "SHOWED WEAK REACTIVITY WITH THE FUNGAL OSPS" - which is normal since they're fungal – their  immune response is turned off to these fungal Osps. 

Yet, as you have just seen, Steere screened those cases out via research fraud in Europe:


1993 - Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.:


So, Allen Steere falsified the case definition for Lyme in 1993 in Europe to deliberately screen out the most severe cases of Lyme - the ones who low antibody concentration, especially in IgG -, so that he and his cabal could later falsify the vaccines using this same criteria … that left out 85% of all cases, all the neurologic cases, and only identified the HLA-linked, autoimmune, “too many antibodies” cases.



Yale owns a patent (5, 618, 533) for valid testing, not used for the OspA vaccine, LYMErix, which they also own:


Band 41, made specific and accurate (see FDA rules for validations of bioanalytical methods):

The Yale, LYMErix, OspA patent (5, 747, 294):


What the Western Blots look like, Normal (NeuroLyme) vs HLA-linked hypersensitivity:

In the above graphic, the ones on the left (neuro) represent normal people with few to no bands, whereas on the right, the people with TOO MANY ANTIBODIES (hence, darker bands and more of them, which refers to antibody concentration) or have an allergy response to Borrelial antigens which are the HLA-linked, hypersensitivity-linked arthritis responses.  These latter people are not sick, they just have bad knees according to Klempner and Wormser in 2005:

A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease.



The above graphic on HLA-linked and non-HLA linked outcomes by Mark Klempner in 2005 shows that there are 2 outcomes to Lyme: Arthritis, where the “Patients feel well aside from their arthritis symptoms,”… and the other 85% with post-septic shock multi-system complaints who are clearly the sickest and never get better. This latter immunosuppression illness was also caused by the OspA vaccines.


So, it is clear:  Since the cabal was formed in 1990 (, these criminals falsified the case definition such as to EXCLUDE everyone who is sick with the neurologic outcome, and INCLUDE everyone who is not sick but just has a bad knee.  It looks like they did not want anyone treated for Lyme at all, ever.



The Czech Children Guinea Pig Stunt


Shapiro and UConn use European children as guinea pigs.  There is none of that kind of OspA in Europe, and they already knew by 1993 that it did not prevent Lyme and was harmful to humans:


J Infect Dis. 1994 Feb;169(2):313-8.  (again, you have seen this before)
Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.  Dressler F1, Ackermann R, Steere AC.
”The antibody responses to the three genomic groups of Borrelia burgdorferi (B. burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii) were determined in 97 German patients with various manifestations of Lyme borreliosis. The geometric mean antibody titers in each patient group, determined by ELISA, were similar with each antigen preparation. By Western blotting, however, patients with meningopolyneuritis tended to respond to more spirochetal polypeptides of B. garinii, the group 2 strain, whereas those with arthritis recognized more antigens of B. afzelii, the group 3 strain (P < .03), as did those with acrodermatitis. Only 1 patient each with erythema migrans, arthritis, or acrodermatitis had weak reactivity with outer surface protein A (OspA), and none responded to OspB. It is concluded that differences among the three groups of B. burgdorferi may result in variations in the antibody response in European Lyme borreliosis.”

And here it shows that less than a 3rd of all Borrelia spirochetes in Europe express the American B31 OspA serotype:


So, for Yale and UConn to use this OspA from strain B31 (LYMErix) on Czech children in Europe is merely “assault” (a criminal charge), because American B31 OspA in Europe would not have done them any good.  They merely assaulted these children to see how bad would be the adverse events:


And once again, these children were never followed. They were observed for 15 minutes following injection and their serum was never tested for antibody levels after one month.



No follow up, no placebo control:  Just whack kids with a vaccine that would do them no good (not much of the B31 kind of OspA in Europe) to see how bad would be the adverse events probably because they know OspA as an immune suppressing fungal antigens do not produce long term antibodies, being a fungal immune suppression triacyl lipoprotein TOXIN.

Who was involved?

Robert Schoen, Durland Fish, Eugene Shapiro (all at Yale), Dave Persing (Mayo Clinic and Corixa)
Henry Feder, Larry Zemel, (Uconn), Lenny Sigal, John Nowakowski, (?) Nadelman, Arthur Weinstein, JJ Halperin,

CDC Officers and Patenteers: Alan Barbour, Barbara Johnson,
CDC officers Paul Mead, Allen Steere, Mark Klempner,
Gary Wormser (NYMC, founding member of the
John J. Connolly (NYMC, founding member of the
Others at the CDC
 Paul Auwaerter (Johns Hopkins)
All the OspA accines trials administrators
The 1998 Vaccines Reports (ImmuLyme and LYMErix):
LYMErix results (76% "safe and effective"): 
ImmuLyme results (92% "safe and effective"): 

Vijay Sikand
Stanley Plotkin
Jeremy Gray
Susan O'Connell



Appendix A:  RICO and “Color of Law” charges


RICO:   << Go ahead and read these.



“Color of Law” – means falsely using one’s authority to deny rights, such as is the slander and libel against Lyme and CFIDS victims by CDC officers and “health department officials” particularly in the State of CT which stood to profit (Uconn) by participating in Yale’s fake LYMErix trials, especially of Czech children (Shapiro, Zemel, Feder). 

This is a particularly serious charge, especially if there is a State health department official who participated in any of Yale’s, SmithKline’s, or ImmuLyme’s (other OspA) vaccine trials., or a CDC officer that published a misogynistic, unreferenced book (eg., Alan Barbour)




18 U.S. Code § 242 - Deprivation of rights under color of law [means using their official authority as CDC officers changing testing criteria to sell their own products or patents, such as Alan Barbour and Barbara Johnson, and who then slander and libel their victims, depriving them of their rights, access to care, access to Social Security Disability or Insurance income.]

Whoever, under color of any law, statute, ordinance, regulation, or custom, willfully subjects any person in any State, Territory, Commonwealth, Possession, or District to the deprivation of any rights, privileges, or immunities secured or protected by the Constitution or laws of the United States, or to different punishments, pains, or penalties, on account of such person being an alien, or by reason of his color, or race, than are prescribed for the punishment of citizens, shall be fined under this title or imprisoned not more than one year, or both; and if bodily injury results from the acts committed in violation of this section or if such acts include the use, attempted use, or threatened use of a dangerous weapon, explosives, or fire, shall be fined under this title or imprisoned not more than ten years, or both; and if death results from the acts committed in violation of this section or if such acts include kidnapping or an attempt to kidnap, aggravated sexual abuse, or an attempt to commit aggravated sexual abuse, or an attempt to kill, shall be fined under this title, or imprisoned for any term of years or for life, or both, or may be sentenced to death.

(June 25, 1948, ch. 645, 62 Stat. 696; Pub. L. 90–284, title I, § 103(b), Apr. 11, 1968, 82 Stat. 75; Pub. L. 100–690, title VII, § 7019, Nov. 18, 1988, 102 Stat. 4396; Pub. L. 103–322, title VI, § 60006(b), title XXXII, §§ 320103(b), 320201(b), title XXXIII, § 330016(1)(H), Sept. 13, 1994, 108 Stat. 1970, 2109, 2113, 2147; Pub. L. 104–294, title VI, §§ 604(b)(14)(B), 607(a), Oct. 11, 1996, 110 Stat. 3507, 3511.)




Who approved Dearborn [CDC officers who own patents that would be worthless if people know that spirochetal and other tick borne diseases (TBDS) antigens were also fungal-ish and therefore could never be used for test kits or vaccine - the goal of]?

They were the same people on the FDA's various panels to discuss the testing (qualification) and approve LYMErix.

They were the same people who 1) own the patents, 2) changed the testing, 3) approved of their own bogus vaccine(s) and 4) via Color of Law, trashed Lyme and LYMErix victims.

What is the failed vaccine and how do we know they knew?

OspA causes the same disease (What is it, and who says so? Latov, Persing and Schoen, Marks, NIH's Martin and Marques, Philipp, Dattwyler, etc, see the Occam's Razor/Appendix C?)

OspA is fungal, TLR2/1 agonist (triacyl-lipopeptide)

Barbour and Fish libel and slander ("Color of Law," Barbour is a CDC officer):

Barbour’s Misogyny Book, totally unreferenced:

Douglas Dodge’s “LymeTruth”


More Slander and Libel:


In Parallels (has OspA-ish been tried before as a vaccine? Occam's Razor/Appendix C?)



RICO within the RICO (Mayo Clinic and Yale)


Mayo's RICO patent (US Patent # 6, 045, 804),045,804.PN.&OS=PN/6,045,804&RS=PN/6,045,804

This patent reveals they know LYMErix causes a systemic disease like chronic Lyme,  and in this patent they reveal their intended monopoly on post-LYMErix testing for the USA and Canada as they claimed in their advertising:

"Additional uncertainty may arise if the vaccines are not completely protective; vaccinated patients with multisystem complaints characteristic of later presentations of Lyme disease may be difficult to distinguish from patients with vaccine failure."

"The present invention provides a method useful to detect a B. burgdorferi infection in a subject. The method provided by the invention is particularly useful to discriminate B. burgdorferi infection from OspA vaccination, although it is sufficiently sensitive and specific to use in any general Lyme disease screening or diagnostic application. 
Thus, the method of the invention is particularly appropriate for large scale screening or diagnostic applications where only part of the subject population has been vaccinated or where the vaccination status of the population is unknown.”    (See the Mayo advertisement in Appendix B)

Who worked on it [Yale’s Robert Schoen and Mayo's Dave Persing]

KEY CONCEPT:  Why was it done? [Monopoly on all future TBDs testing in USA and Canada once an OspA vaccine was on the market, as shown above. To capture the market for TBDs testing once LYMErix was on the market:  Lyme testing and test kits are more lucrative than vaccines, plus you get to patent all the new pathogens you find in that monopoly blood.]

How does the Mayo patent show a RICO?

Blumenthal's staff asked the author if this cabal ever openly advertised their intentions with this test?
Yes, Mayo Clinic and Yale actually did publish that they would have the only testing you could use to assess for Lyme and TBDs once LYMErix was on the market; that Imugen, Corixa and Yale’s L2 Diagnostics would be the only 3 labs in the country to be licensed to use the RICO patent (6,045,087) method.  (See the Mayo advertisement in Appendix B)

ODDLY, Persing and Sigal later said none of the OspA trials were valid as the Western Blotting was unreadable, but both LYMErix and ImmuLyme trials said they used the Dearborn method to approve these vaccines. The 3 labs, Corixa, Yale's L2 Diagnostics, and Imugen were the only ones licensed to use this patented testing for the post-LYMErix criminal ALDF RICO era:

Clin Infect Dis. 2000 Jul;31(1):42-7. Epub 2000 Jul 17.

Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.


“The manufacturer of the only currently FDA-approved (and released) recombinant OspA Lyme disease vaccine has suggested that vaccination does not interfere with serological evaluation of Lyme disease in vaccine recipients—a statement that is not supported by the data presented here.

Neither of the 2 OspA vaccine teams could actually read their Western Blots, yet they falsely claimed they had qualified the safety and efficacy of those vaccines, ImmuLyme and LYMErix.


Appendix A, part II – Mayo Advertising their intent; “the RICO within the RICO”


“Mayo Clinic Rochester News, Tuesday, August 4, 1998

“New Tests Set Standard for Diagnosing Lyme Disease

“ROCHESTER, MINN. — Mayo Medical Laboratories and IMUGEN Inc. announced today the newest and most accurate test series available for diagnosing Lyme disease. The tests also are  the only reliable means of diagnosing Lyme disease in people who have been vaccinated against Lyme disease.
  “Mayo Medical Laboratories, the laboratory for Mayo Clinic, and IMUGEN Inc. of Norwood, Mass., are jointly offering the new proprietary tests through local hospitals and clinics. Availability of the new tests coincides with the anticipated release of new Lyme disease vaccines, such as the widely-publicized LYMErix and ImuLyme. 
”In research trials, all other Lyme tests have been shown to produce false-positive results in people vaccinated against Lyme disease. Moreover, the downstream costs of medical care delivered on the basis of just one false-positive Lyme test can be as much as $15,000.
  “According to Dr. David Persing, a Mayo Clinic molecular biologist involved in the discovery of the new test components, physicians now have a new and more reliable means of diagnosing patients who present with symptoms of Lyme disease.
  "These tests should help reduce the human and financial costs associated with the number of undiagnosed, misdiagnosed, untreated or improperly treated patients," Dr. Persing added. 
  ”Scientists at IMUGEN, recognized nationally as the leading reference laboratory for tick-borne diseases, are responsible for developing the highly accurate immunologic methods to utilize Dr.Persing’s discovery.  [It was Schoen at Yale, unless Steere really is a partner at Imugen as some Lyme activists have claimed. – SASH]
  "Diagnosing Lyme disease has been highly problematic for a long time," said Victor Berardi, chief executive officer of IMUGEN, whose laboratories have performed more than a half-million Lyme disease tests. "Our new tests will greatly help physicians in distinguishing patients who are actually infected from those who aren’t. Furthermore, the accuracy of these tests will not be affected by Lyme vaccine. In any case, the tests will help physicians render more appropriate and cost effective care."
   “Lyme disease is a tick-borne illness that if left undiagnosed or untreated can severely damage the human heart and nervous system. Nationally more than 16,000 cases of Lyme disease were reported to the Centers for Disease Control and Prevention (CDC) in 1996. The majority of cases were reported in New England and the Northeast. The CDC reports that the overall number of Lyme disease cases could climb to 25,710 by the year 2000.
  “In a study of 10,936 people in states with a high incidence of Lyme disease, one new vaccine proved 79 percent effective at preventing Lyme disease infections after complete dosage. Given the potential popularity of the vaccine, and the recent epidemic of Lyme disease in the Northeast, the new tests offered by Mayo Medical Laboratories and IMUGEN will be of considerable value. 
  ”The new Lyme disease tests detect multiple classes of antibody isotypes, enabling them to discriminate between the vaccine and a true Lyme infection. Existing Lyme disease tests, however, have shown to produce false-positive results in patients vaccinated for Lyme disease.
  “IMUGEN Inc. of Norwood, Mass., is a pioneer in the research, development and testing of tick-borne diseases, including Lyme disease, babesiosis and ehrlichiosis. For the past decade, IMUGEN has provided clinics and hospitals in the Northeast with high-quality serologic testing from its facilities in Norwood, Mass., and Southhampton Hospital in Southhampton, N.Y. For more information, call 781-255-0770.
  “Mayo Medical Laboratories is the laboratory for Mayo Clinic and provides lab services to community-based healthcare organizations throughout the nation and world. Mayo Medical Laboratories draws from the expertise of Mayo Clinic’s 1,600 physicians and scientists who provide specialized consultation on test selection, utilization and interpretation.
“For information, call 800-533-1710. “Contact: “Tom Huyck, “507-284-0003 (days)
“507-284-2511 (evenings)”


Appendix B --  HLAs and TLRs, Autism vaccines;  The kids are getting the viruses and not in the classic “autoimmune, inflammatory” way




HLA-linked hypersensitivity (="Autoimmune," "inflammatory," ...) –  What are the HLAs?  They are the genetically encoded clam-shaped molecules in “professional antigen presenting cells like macrophages and B cells that “present antigen” against which antibodies to be made.  Here we see Wikipedia showing that the HLA’s SHAPE is genetically determined.  There is a variety.  The people with Lyme arthritis have a certain type of HLA clam-shaped molecule that results in over- or chronic stimulation, such as an allergy or is called hypersensitivity.  This is the 15% who continue to make antibodies against Lyme and are not sick.  The 85% of us without Lyme arthritis allergy or autoimmunity stop making antibodies because the fungal Osps are seen as serious toxins.

Khan Academy explainer on MHCs or HLAs




This “Major Histocompatability Complex” business has to do with, originally, tissue rejection in transplants.  When they look for a donor “match” they want to make sure the donor and the recipient have the same HLAs, so the tissue will not be rejected as “foreign.”  (That was how they were discovered.)


Toll Like Receptors take the antigen *IN,* then some physiochemical changes happen, the bug is broken up, then the 2 clam shaped HLA molecules "PRESENT" antigen *OUT* to the surface of the cell so the other immune cells can see, "Hey, THIS is a bad guy." When the antigen is a fungal toxin like LYMERIX??? The HLA molecules no longer PRESENT ANTIGEN and you make no more antibodies - not even against VIRUSES, due to CROSS TOLERANCE shown here:


"Because IRAK1 is required for TLR7/9-induced IFN-I production, we propose that TLR2 signaling induces rapid depletion of IRAK1, which impairs IFN-I induction by TLR7/9. This novel mechanism, whereby TLR2 inhibits IFN-I induction by TLR7/9, may shape immune responses to microbes that express ligands for both TLR2 and TLR7/TLR9, or responses to bacteria/virus coinfection."


In Lyme and LYMErix disease, the HLA molecules are “down-regulated” or stop “presenting antigen” because this is a way of STOPPING DEATH (prevents apoptosis) from the “cytokine storm” in sepsis.  This co-occurs in other cases such as in Tuberculosis and in other trials of vaccines with the same type of antigen, fungal or triacyl (TLR2/1 agonists):



Watch the Khan Academy and similar videos on immunology, especially the one about “Professional Antigen-Presenting Cells” and HLA/MHC molecules.


TLR2/1 agonists (lipoproteins, triacylated);
TLR agonist tolerance and cross tolerance Osps turn off the response to viruses (TLR7/9), CV Harding:


"Great Imitator" = something that sets off the variety show of syndromes after TLR2/1 agonist sepsis or polymicrobial sepsis; the diagnosable ones being due to the secondary opportunistics, like Cancer, Lupus & MS (EBV, etc). Arthritis is allegedly more due to foreign fungal antigens and allegedly heat shock proteins.

Exosomes, Blebs:  Steere recognized relative abundance of exported blebs in knees with Duray in early 1990s. You may ask what is responsible for the ongoing stimulation in the 15%, the arthritis, HLA-linked cases. 

Infect Immun. 2010 Dec;78(12):5116-25. doi: 10.1128/IAI.01089-09. Epub 2010 Sep 13.

Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation.

Ramachandra L1, Qu Y, Wang Y, Lewis CJ, Cobb BA, Takatsu K, Boom WH, Dubyak GR, Harding CV.

“Thus, infection with M. tuberculosis primes macrophages for the increased release of exosomes and microvesicles bearing M. tuberculosis peptide-MHC-II complexes that may generate antimicrobial T-cell responses.”

Is it possible that a response to these fungal antigens is to release the whole MHC/HLA-II Plus Antigen complex, which then again becomes a new free antigen in itself?  Is this what Steere saw when he claimed that there was a cross reaction with HLA molecules as a cause of the ”autoimmunity” in Lyme arthritis?



Having a “Disease” without classic “Inflammation” or “Autoimmunity” – This FRAUD has to do with the Autism pandemic:

The Lyme criminals claim you can’t have a “disease” unless you have inflammation or an autoimmune outcome.  Of course, such a claim betrays the source of the Autism pandemic.  The kids are getting the viruses instead of the protection and this is shown in many places and is called an “adverse event.”


Yale’s Eugene Shapiro in PBS’ “Life on Earth Series”:


”TOOMEY: But most physicians think there's good reason to discount the possibility of chronic Lyme Disease.

”SHAPIRO: What some people would have you believe is that there are two different diseases.

”TOOMEY: Yale physician Eugene Shapiro says first, take the obvious case of Lyme Disease that usually starts with a distinctive rash and can lead to arthritis and facial paralysis.

“SHAPIRO: Somehow, for that form of the disease, antibiotics are effective. They do fine. But then there's some other form of the disease which is, you can't put your hand around it. They don't have objective findings of inflammation, which is the way bacteria cause disease.

”TOOMEY: What these patients do have are symptoms that doctors call nonspecific. They span a broad spectrum. Emotional problems, as in the case of Lisa's daughter; or fatigue, muscle pains, depression. Doctor Shapiro helped write the Lyme treatment guidelines put out by the Infectious Diseases Society of America. Guidelines that state even the most advanced cases of infection can be eradicated with two months of oral or intravenous antibiotics. But for the patients with these ongoing, nonspecific symptoms, the maximum treatment didn't seem to work.

”SHAPIRO: They would have you believe that form of the disease, somehow this is, the bacteria knows to act differently and it doesn't respond to antibiotics in this sense. It really doesn't make any sense.




Of course it does make sense: Spirochaeta are not bacteria, in the sense that 1) they are their own Phylum, 2) shed fungal antigens and 3) have no LPS.  But, what would Shapiro know about science?  His undergraduate degree is in English Literature.  The point is, you see here, Shapiro, et al, claim that you can’t have a disease unless you have inflammation or an autoimmune one.  Spirochetes are notorious immune suppressors like Tuberculosis because the Osps are triacylated lipoproteins, which means they are managed by Toll Like Receptors 1 and 2, and which means they are FUNGAL.  (Which means THEY ARE NOT REGULAR “BACTERIA.”)


Check the “Contraindications” of the MMR monograph by Merck: 


”Histologic changes, similar to those seen in gestational rubella, have been observed and rubella virus has been recovered from decidua following vaccination of pregnant women with live attenuated rubella vaccine. These vaccines may thus constitute a risk to the fetus.

“Active untreated tuberculosis. Patients receiving immunosuppressive therapy with ACTH, corticosteroids, irradiation, alkylating agents or antimetabolites. This contraindication does not apply to patients who are receiving corticosteroids as replacement therapy, e.g., for Addison’s disease. Individuals with blood dyscrasias, leukemia, lymphomas of any type, or other malignant neoplasms affecting the bone marrow or lymphatic systems. Primary and acquired immunodeficiency states, including patients who are immunosuppressed in association with AIDS or other clinical manifestation of infection with human immunodeficiency viruses; cellular immune deficiencies, hypogammaglobulinemic and dysgammaglobulinemic states. Measles inclusion body encephalitis (MIBE), pneumonitis and death as a direct consequence of disseminated measles vaccine virus infection has been reported in severely immunocompromised individuals inadvertently vaccinated with measles-containing vaccine…”      


The above all means: don’t vaccinate someone who is immunosuppressed or already has an infection especially a fungal one (like Lyme or LYMErix disease) because the victim can become damaged from the live virus, and which is not an “autoimmune” outcome.


Check also Wikipedia on the topic of “Attenuated Vaccines:” 


“Secondary mutation can cause a reversion to virulence.[7]

“Can cause severe complications in immunocompromised patients.[8]

“Some can be difficult to transport due to requirement to maintain conditions (e.g. temperature)


Check the CDC when in their patents they claim vaccines fail by giving people the actual virus the vaccines are intended to prevent:

CDC’s Patent, US # 7,632,510, 
Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

"Finally, there is the risk that the virus may not be fully or completely inactivated or attenuated and thus, the vaccine may actually cause disease.",632,510.PN.&OS=PN/7,632,510&RS=PN/7,632,510

CDC SAYS,…Measles, Mumps, and Rubella -- Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

"Updated information on adverse events and contraindications, particularly for persons with severe HIV infection, persons with a egg allergy or gelatin allergy, persons with a history of thrombocytopenia, and persons receiving steroid therapy."  [are immunosuppressed, steroids cause immunosuppression- KMD] 

CDC SAYS: Human Exposure to Brucella abortus Strain RB51 -- Kansas, 1997

[In the above, an immunosuppressed pregnant cow was given a Brucella (LYMErix-like) "live attenuated" vaccine and the baby cow ended up with the disease, which then was transferred to the humans handling the cow and her dead baby. This parallels what is happening to children who are vaccinated while immunosuppressed, or who receive mycoplasmally (LYMErix-like) contaminated vaccines -$A$H.]

Check out Paul Auwaerter’s experiment where he harvested a live virus from a child and said of this activity:
”… and ****a virus isolated from an immunodeficient child with progressive vaccine-induced disease (Hu2).**** …”

Therefore, many times the CDC and other have said the reasons vaccines fail is because of immunosuppression or the live attenuated viruses become live, virulent viruses.


Thimerosal was even put in vaccines to PREVENT the occurrence of co-injecting fungal (contamination) antigens together with the live viruses in vaccines, because when you inject both fungal antigens and live viruses together, the immunosuppression from the fungal antigens (like LYMErix, or OspA) you get the viruses reactivated:

2012, Dec, NYTimes; Vaccine Rule Is Said to Hurt Health Efforts
"But a proposal that the ban include thimerosal, which has been used since the 1930s to prevent bacterial and fungal contamination in multidose vials of vaccines, has drawn strong criticism from pediatricians…. They say that the ethyl-mercury compound is critical for vaccine use in the developing world, where multidose vials are a mainstay…Banning it would require switching to single-dose vials for vaccines, which would cost far more and require new networks of cold storage facilities and additional capacity for waste disposal, the authors of the articles said.'"     

See what the effect is of injecting fungally contaminated vaccines into newborns even without the live viruses:


Brain Behav Immun. 2015 Aug;48:301-12. doi: 10.1016/j.bbi.2015.04.020. Epub 2015 May 27.

Postnatal TLR2 activation impairs learning and memory in adulthood.


"Neuroinflammation in the central nervous system is detrimental for learning and memory, as evident form epidemiological studies linking developmental defects and maternal exposure to harmful pathogens. Postnatal infections can also induce neuroinflammatory responses with long-term consequences. These inflammatory responses can lead to motor deficits and/or behavioral disabilities. Toll like receptors (TLRs) are a family of innate immune receptors best known as sensors of microbial-associated molecular patterns, and are the first responders to infection. TLR2 forms heterodimers with either TLR1 or TLR6, is activated in response to gram-positive bacterial infections, and is expressed in the brain during embryonic development. We hypothesized that early postnatal TLR2-mediated neuroinflammation would adversely affect cognitive behavior in the adult. Our data indicate that postnatal TLR2 activation affects learning and memory in adult mice in a heterodimer-dependent manner. TLR2/6 activation improved motor function and fear learning, while TLR2/1 activation impaired spatial learning and enhanced fear learning. Moreover, developmentalTLR2 deficiency significantly impairs spatial learning and enhances fear learning, stressing the involvement of the TLR2 pathway in learning and memory. Analysis of the transcriptional effects of TLR2 activation reveals both common and unique transcriptional programs following heterodimer-specific TLR2 activation. These results imply that adult cognitive behavior could be influenced in part, by activation or alterations in the TLR2pathway at birth."

And an experiment from the 1950s where fungi (mycoplasma) were injected together with live viruses to show exactly how this dual injection thing works:

"In Swiss mice, animals with high natural resistance to hepatitis virus, the pathogenicity of this agent was markedly enhanced by combined infection with eperythrozoa. Eperythrozoa were maintained throughout 18 successive passages in normal Princeton and Swiss weanlings with intact spleens. The combined infection of Princeton mice with eperythrozoa and the virus component of Gledhill, Dick, and Andrewes, which is nearly inactive when injected alone, resulted in acute hepatitis with fatal outcome." 





In the case of the MMR vaccine damage, Borna virus is a model of the “neurodevelopmental damage” known as Autism.


The Infectious Diseases Society of America said this about the brain damaging vaccines:


“21st Century Cures Act: Boosting Antimicrobial Development, Constraining Vaccinations

by Marie Rosenthal

“Amanda Jezek, the vice president of Public Policy and Government Relations at the Infectious Diseases Society of America (IDSA), in Arlington, Va., said there is concern that this push to recommend a vaccine before the ACIP has reviewed the evidence would completely “jeopardize the integrity of ACIP’s recommendations.”


“Most of the vaccinations given in this country are received by those younger than 2 years of age, so assuring the safety and efficacy of vaccines is paramount. Every year, more than 40 million vaccines are given to children younger than 1 year of age, usually between 2 and 6 months of age, Dr. Temte said. At this age, infants are at greatest risk for certain serious medical adverse events, including high fevers, seizures and sudden infant death syndrome, according to the U.S. Vaccine Adverse Event Reporting System. Therefore, it is important for the ACIP to consider carefully the risks versus the benefits before making a recommendation rather than be on a forced schedule that suits the manufacturer as opposed to the patient.

a recommendation rather than be on a forced schedule that suits the manufacturer as opposed to the patient.”  






Appendix D: MaryBeth Pfeiffer in the HuffPo, Jan 2017, re: CDC’s falsified Dearborn case definition

Flunk the Lyme test? Just wait and get sicker

 01/09/2017 03:49 pm ET | Updated Jan 09, 2017


 Mary Beth Pfeiffer is an investigative journalist who is writing a book, “The First Epidemic,” on the global spread of ticks and the diseases they carry. Follow her on Twitter: @marybethpf


“….Tests: ‘Stop-gap measure’

”In researching my book on the global spread of tick-borne disease, I spoke about the testing regimen with Raymond Dattwyler, an author of the Lyme protocols who was on the 1994 CDC panel that wrote the test guidelines. He was frank about its failures.

“’They were a stop-gap measure,’ he told me. ‘Twenty years ago I would’ve said they’re fine. Now I say, ‘oh shit, we were wrong.’ It doesn’t look as good as we thought it was….’”

”False positives: ‘Red herring’…


“… Benjamin Luft, a physician who wrote the original Lyme disease guidelines in 2000 but who now sees them as flawed on the issue of whether Lyme disease can persist, called the false positive issue ‘a red herring.’


“’I think there’s a great deal of benefit for early treatment than delay,’ he said in an interview. ‘It does become progressively more difficult [to treat] as time goes on.’




The “red herring” is that no treatment really helps even if caught early. Half still go on to chronic illness (Dattwyler, Luft, UCSF’s Chiu), but Dearborn was research fraud that was performed to ALSO (also in addition to deny all treatment, early – as shown by excluding all the IgM cases -, and late neurologic Lyme) put out a “vaccine” that caused the same chronic, neurologic, immunosuppression disease. 

All the victims, of tick bite and OspA “vaccine,” were slandered and libeled in order to make those LYMErix-Post-Sepsis Adverse Events cases look like “Crazy” cases. 

The Dearborn case definition was created from research fraud.

The Klempner “re-treatment” “study” was research fraud and a false claim (based on Dearborn).

The OspA vaccines were research fraud, false claims and assault (based on Dearborn; OspA was Pam3Cys or a triacyl lipoprotein, which is a fungal TOXIN that caused global immunosuppression or post-septic shock).





APPENDIX E:  What is OspA? 

A triacyl lipopeptide, which means handled by TLR2 and 1 and is fungal.  A recombinant fungal antigen could never have been a vaccine, and when tried elsewhere faled in the same way LYMerix failed, by causing immunosuppression and rendering people more susceptible to disease.

Tripalmitoyl Cysteine, or Pam3Cys means 3 palmitic acid groups or 3 groups of basically, palm oil (the zig-zaggy lines refer to carbon-carbon-carbon, each with 2 hydrogens on them).  


This graphic comes from a Korean Chemistry journal not listed in PubMed, talking about either HIV’s gp120 or a vaccine designed with Pam3Cys added on, the language is confusing:

Characterization of Extremely Hydrophobic Immunostimulatory Lipoidal Peptides by Matrix Assisted Laser Desorption Ionization Mass Spectrometry


Anyone can go to the National Library of Medicine and find that OspA is Pam3Cys or a triacylated lipopeptide and never could have been a vaccine:


Vaccine. 1997 Jun;15(9):988-96.

OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant.


“The outer surface protein A (OspA) lipoprotein of Borrelia burgdorferi, like cholera toxin and the heat-labile enterotoxin of Escherichia coli, induces pro-inflammatory cytokines. This suggested that, like those toxins, OspA might be a mucosal immunogen and adjuvant. OspA, administered intranasally (i.n.) or intragastrically, induced strong serum IgG and salivary gland IgA responses. The serum IgG isotypes were indicative of a mixed T helper 1 and T helper 2 response, the latter being more pronounced. The N-terminal tripalmitoyl-S-glyceryl-cysteine (Pam3Cys) lipid moiety was absolutely required. OspA strongly enhanced the serum IgG and salivary gland IgA responses to jack bean urease co-administered by the i.n. route. OspA also enhanced the response to tetanus toxoid and induced limited protection against challenge. A synthetic lipopeptide also adjuvanted the response to urease by the i.n. route, but was ca 500-fold less potent on a molar basis than OspA. These results suggest that OspA or other lipoproteins may be useful in mucosal vaccines.”



Infect Immun. 1999 Jan;67(1):140-7.

Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.


“We previously showed that heat-killed Borrelia burgdorferi spirochetes and lipidated outer surface protein A (L-OspA) stimulated the in vitro production of interleukin-10 (IL-10) in peripheral blood mononuclear cells (PBMC) from uninfected humans and rhesus monkeys (G. Giambartolomei et al., Infect. Immun. 66:2691-2697, 1998). Here we demonstrate that uninfected human peripheral blood monocytes, but not B or T cells, are the cells that transcribe the IL-10 cytokine gene in response to heat-killed B. burgdorferi. B. burgdorferi similarly induced an upregulation of the IL-1beta and IL-6 cytokine genes in monocytes and the production of IL-10 and IL-6 in culture supernatants of the human monocytic cell line THP-1. Purified L-OspA (but not unlipidated OspA [U-OspA] or U-OspC) also stimulated the production of both cytokines in THP-1 cells in a dose-dependent fashion, suggesting that acylation of the OspA protein molecule is required for the production of both anti- and pro-inflammatory cytokines in naive monocytes. A lipohexapeptide that contained the tripalmitoyl-modified cysteine motif (Pam3Cys-Hex) of B. burgdorferi lipoproteins but with an arbitrary peptide sequence had the same effect. Monoclonal antibodies (MAbs) MY4 and 60bca, both of which bind to CD14 and are known to block lipopolysaccharide (LPS)-mediated cytokine production, were able to block L-OspA-mediated IL-10 and IL-6 cytokine production. In contrast, MAb 26ic, which also binds to CD14 but does not block LPS function, failed to inhibit L-OspA-mediated cytokine production. These data suggest that activation of monocytes and production of both anti- and pro-inflammatory cytokines induced by lipoproteins proceeds via the CD14 receptor. LPS binding protein was not required for OspA-induced cytokine production. Our results demonstrate that pro- and anti-inflammatory cytokines induced by B. burgdorferi lipoproteins in PBMC are produced by monocytes and that lipoprotein and LPS signaling pathways share at least the initial signaling event that involves the CD14 receptor.

What those 2 reports mean are that:
1) that Pam3Cys, or OspA is 500 times more toxic when injected than inhaled (think mold inhalation could be bad, too, but not directly as devastating), and that you needed the Pam3Cys or the fatty acids in order for OspA to be a toxin.

And 2) the second report means that it does not matter what the protein end is, it’s not very immunogenic by itself. It’s the Pam3Cys or the central structure shown here (above) that is the poison.

After the initial “cytokine storm” of Lyme or LYMErix sepsis, this:

J Innate Immun. 2016;8(2):171-84. doi: 10.1159/000440838. Epub 2015 Oct 13.

Endotoxin Tolerance Inhibits Lyn and c-Src Phosphorylation and Association with Toll-Like Receptor 4 but Increases Expression and Activity of Protein Phosphatases.

Endotoxin tolerance protects the host by limiting excessive “cytokine storm” during sepsis, but compromises the ability to counteract infections in septic shock survivors. It reprograms Toll-like receptor (TLR) 4 responses by attenuating expression of pro-inflammatory cytokines without suppressing anti-inflammatory and antimicrobial mediators, but the mechanisms of reprogramming remain unclear. In this study, we demonstrate that induction of endotoxin tolerance in human monocytes, THP-1 and MonoMac-6 cells inhibited lipopolysaccharide (LPS)-mediated phosphorylation of Lyn, c-Src and their recruitment to TLR4 but increased total protein phosphatase (PP) activity and expression of protein tyrosine phosphatase (PTP) 1B, PP2A, PTP non-receptor type (PTPN) 22, and mitogen-activated protein kinase phosphatase (MKP)-1.  …

“During infection and inflammation, microbial components and endogenous “alarmins” activate membrane-associated Toll-like receptors (TLRs) expressed on macrophages, dendritic cells, and neutrophils to activate innate immunity and prime adaptive immune responses [1]. TLRs contain an ectodomain with multiple leucine-rich regions involved in ligand sensing and co-R interactions, a transmembrane domain, and a cytoplasmic tail with a signaling Toll-IL-1R (TIR) domain [1,2]. TLR2 cooperates with TLR1 or TLR6 to detect tri- and di-acylated lipoproteins expressed by Gram positive bacteria, mycobacteria and mycoplasma [3,4].  


As you can see ^^^  TLR2/1 handles triacyl lipoproteins, which are basically fungal.  In any event, this is all well-known to the infectious diseases science world.  Anyone can look up what OspA is, find it is handles by TLR2 and 1, and therefore is fungal-ish.   Humans cannot be injected with fungal antigens.  They’re toxins.


Why did the Lyme criminals think they could go ahead and do this and no one would see what they were up to?   The first reason is that you can’t re-crystallize a lipid (butter never exactly freezes along cleavage lines like a true solid).  The normal way to get a structure is by X-ray diffraction studies, but this can’t be done with an amorphous blob.  Therefore the bad guys SAY, and HAVE SAID (Barbour), “We don’t know what OspA is”. 

They can’t now say what it is, can they?  The SECOND they say “OspA is Pam3Cys,” the whole world will know it could never have been a vaccine and Yale must have lied about it to the FDA (which of course they did).  Even the NIH and CDC to this day (Yale, too) when asked, say “We don’t know what OspA is.”  Why do they say that?  Think.  ‘Pretty embarrassing for no one to have been watching what Edward McSweegan was up to – in charge of Lyme grants at the NIH !!

What other vaccine attempts with the likes of Pam3Cys or where the likes of the immune suppressing OspA has been co-injected with viruses,…

and has this model of post-septic shock or an immune suppressed state been seen to result in reactivated latent viruses like Epstein-Barr and Cytomegalovirus?

At least four.  And certainly – and we even see them every day on the television (Humira, Stelara ads). 

We call this an Occam’s Razor (“All roads lead to…,” or “If it walks like a duck…”).  Chronic Fatigue from post sepsis syndrome is the results of the reactivation of these latent viruses.  When people have the HLAs for a hypersensitivity response to one or more of the opportunistic (see Fauci’s patent) infections that take hold after immune suppressing sepsis, they might have an AUTOIMMUNE or HYPERSENSITIVITY or ALLERGY response, such as to EBV, such as MS or Lupus.  This is why MS and Lupus are well known “Great Imitator” (syphilis) and “New Great Imitar” (Lyme) outcomes.  Less well received by the “medical” community is the notion that one might have a disease without inflammation (See Shapiro, above). 



THREE Tuberculosis (remember, MYCO means fungi) failed vaccine reports:

”… Induction of an immune response to the 19-kD antigen by an alternative approach of DNA vaccination had no effect on subsequent M. tuberculosis challenge. These results are consistent with a model in which the presence of the 19-kD protein has a detrimental effect on the efficacy of vaccination with live mycobacteria.”


“… Thus, the immunosuppressive effect is dependent on glycosylated and acylated 19-kDa lipoprotein present in the phagosome containing the mycobacterium. These results suggest that the diminished protection against challenge with M. tuberculosis seen in mice vaccinated with M. smegmatis expressing the 19-kDa lipoprotein is the result of reduced TNF-alpha and IL-12 production, possibly leading to reduced induction of T-cell activation.”


“… This study indicates that the 27-kDa antigen has an adverse effect on the protection afforded by recognized vaccines. We are currently studying how the 27-kDa antigen modulates the mouse immune response.”

Clifford Harding on how fungal toxins like OspA turn off the immune response to viruses like EBV:

Because IRAK1 is required for TLR7/9-induced IFN-I production, we propose that TLR2 signaling induces rapid depletion of IRAK1, which impairs IFN-I induction by TLR7/9. This novel mechanism, whereby TLR2 inhibits IFN-I induction by TLR7/9, may shape immune responses to microbes that express ligands for both TLR2 and TLR7/TLR9, or responses to bacteria/virus coinfection.”


An experiment injecting mycoplasma and live viruses together:


“In Swiss mice, animals with high natural resistance to hepatitis virus, the pathogenicity of this agent was markedly enhanced by combined infection with eperythrozoa. Eperythrozoa were maintained throughout 18 successive passages in normal Princeton and Swiss weanlings with intact spleens. The combined infection of Princeton mice with eperythrozoa and the virus component of Gledhill, Dick, and Andrewes, which is nearly inactive when injected alone, resulted in acute hepatitis with fatal outcome.”


’Which is why Thimerosal is put in vaccines – to prevent fungi -, since the immunosuppression results in reactivated viruses and this is actually a well-known thing.



Where else do we see immunosuppression resulting in reactivate latent herpesviruses?

 Stelara, Humira (“lymphoma” warnings, which means EBV) commercials, transplant victims. hospital sepsis victims, astronauts and medical school student due to their cortisol (stress !!) induced immunosuppression (Chronic Fatigue from reactivated Mono) and disruption of their sleep-wake cycle…


You see it and you hear about it every day.


Only one thing predictably happens in immunosuppression:  EBV, et al, have a free for all.  And guess what, there is no vaccine against it, since such prevention would put BigPharma out of business, wouldn’t it. 





Mono: Symptoms, Diagnosis and Treatment Options  Sep, 2014

"People believe that it is common to have a chronic mono infection that can cause problems for years. This is really not the case," said Hymes. EBV is a viral illness in the same family as herpes and varicella (chickenpox). Like those other members of the herpes virus family, the virus can stick around in your body, Hymes explained. However, the virus is dormant and only very rarely reactivates, usually in times of stress. "Chronic active Epstein-Barr infection is something we really only see in people with immune problems — transplant patients, HIV patients, or people born missing a part of their immune system or immune function," said Hymes. Lab testing can detect chronic presence of the virus and can rule it out, so it is easily diagnosed.


“Some studies suggested that acute infectious mononucleosis and Epstein-Barr virus may permanently alter or impair the immune response. A 2007 Danish study looked at the possible correlation between multiple sclerosis and infectious mononucleosis and found that the risk of multiple sclerosis was persistently increased for more than 30 years after contracting infectious mononucleosis.

Mono may also be responsible for chronic fatigue syndrome. EBV persistence in the muscles biopsy samples, when looked at in patients with post-viral muscle fatigability, is seen far less commonly (9%) then in patients recovering from enterovirus infections (24%) according to a study done by the Department of Biochemistry at Charing Cross and Westminster Medical School, London, UK.



The “Three Times More Coxsackie in the Muscles Than Post-Sepsis EBV-ish Chronic Fatigue/ME Syndrome” Report referenced above:


Br Med Bull. 1991 Oct;47(4):852-71.

Persistent virus infection of muscle in postviral fatigue syndrome.

Cunningham L1, Bowles NE, Archard LC.

Author information


“Nucleic acid was extracted from muscle biopsy samples from a series of highly selected patients suffering from chronic muscle fatiguability following a viral infection (Postviral Fatigue Syndrome: PVFS). Samples were examined for the presence of enteroviral RNA sequences or Epstein-Barr (EBV) virus DNA sequences by molecular hybridisation as these two agents have been implicated by retrospective serology in the aetiology of PVFS. We found enteroviral RNA in 24% of biopsy samples and EBV DNA in a further 9% of biopsy samples: no biopsy was positive for both enteroviral RNA and EBV DNA. In addition, in the case of enteroviruses we found that the persisting virus is defective in control of RNA replication as both strands of enteroviral RNA are present in similar amounts: this is unlike the asymmetric synthesis of genomic RNA seen in a productive, cytolytic enterovirus infection. The implications of these data in relation to mechanisms of viral persistence and muscle dysfunction are discussed.”



J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1382-6.

Enterovirus related metabolic myopathy: a postviral fatigue syndrome.

Lane RJ1, Soteriou BA, Zhang H, Archard LC.

“To detect and characterise enterovirus RNA in skeletal muscle from patients with chronic fatigue syndrome (CFS) and to compare efficiency of muscle energy metabolism in enterovirus positive and negative CFS patients.

METHODS:  Quadriceps muscle biopsy samples from 48 patients with CFS were processed to detect enterovirus RNA by two stage, reverse transcription, nested polymerase chain reaction (RT-NPCR), using enterovirus group specific primer sets. Direct nucleotide sequencing of PCR products was used to characterise the enterovirus. Controls were 29 subjects with normal muscles. On the day of biopsy, each CFS patient undertook a subanaerobic threshold exercise test (SATET). Venous plasma lactate was measured immediately before and after exercise, and 30 minutes after testing. An abnormal lactate response to exercise (SATET+) was defined as an exercise test in which plasma lactate exceeded the upper 99% confidence limits for normal sedentary controls at two or more time points.


Muscle biopsy samples from 20.8% of the CFS patients were positive for enterovirus sequences by RT-NPCR, while all the 29 control samples were negative; 58.3% of the CFS patients had a SATET+ response. Nine of the 10 enterovirus positive cases were among the 28 SATET+ patients (32.1%), compared with only one (5%) of the 20 SATET- patients. PCR products were most closely related to coxsackie B virus.

CONCLUSIONS: There is an association between abnormal lactate response to exercise, reflecting impaired muscle energy metabolism, and the presence of enterovirus sequences in muscle in a proportion of CFS patients.



Conclude: Coxsackie/Enteroviruses plus reactivated Epstein-Barr, Cytomegalovirus etc., may all contribute to these serious illnesses.  And although we have the analytical methods to look for more common viruses/fungi and the biomarkers (sub-immunity, plus biomarkers of CNS degradation), patients with “Chronic Lyme” or CFIDS/ME are not taken seriously.  They’re abused and slandered against instead.  The mechanisms of illness in these conditions betray the source of the Autism pandemic from the childhood vaccines.  These are Color of Law abuses to hide Fraud.


Additionally, spirochetes target the lymph nodes, and damage the B cell maturations or germination centers there, rendering the victims unable to fight off non-fungal infections, says Ucal, Davis:

PLoS Pathog. 2015 Jul 2;11(7):e1004976. doi: 10.1371/journal.ppat.1004976. eCollection 2015.

Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection.

Elsner RA1, Hastey CJ1, Olsen KJ2, Baumgarth N3.

Author information


Lyme Disease caused by infection with Borrelia burgdorferi is an emerging infectious disease and already by far the most common vector-borne disease in the U.S. Similar to many other infections, infection with B. burgdorferi results in strong antibody response induction, which can be used clinically as a diagnostic measure of prior exposure. However, clinical studies have shown a sometimes-precipitous decline of such antibodies shortly following antibiotic treatment, revealing a potential deficit in the host's ability to induce and/or maintain long-term protective antibodies. This is further supported by reports of frequent repeat infections with B. burgdorferi in endemic areas. The mechanisms underlying such a lack of long-term humoral immunity, however, remain unknown. We show here that B. burgdorferi infected mice show a similar rapid disappearance of Borrelia-specific antibodies after infection and subsequent antibiotic treatment. This failure was associated with development of only short-lived germinal centers, micro-anatomical locations from which long-lived immunity originates. These showed structural abnormalities and failed to induce memory B cells and long-lived plasma cells for months after the infection, rendering the mice susceptible to reinfection with the same strain of B. burgdorferi. The inability to induce long-lived immune responses was not due to the particular nature of the immunogenic antigens of B. burgdorferi, as antibodies to both T-dependent and T-independent Borrelia antigens lacked longevity and B cell memory induction. Furthermore, influenza immunization administered at the time of Borrelia infection also failed to induce robust antibody responses, dramatically reducing the protective antiviral capacity of the humoral response. Collectively, these studies show that B. burgdorferi-infection results in targeted and temporary immunosuppression of the host and bring new insight into the mechanisms underlying the failure to develop long-term immunity to this emerging disease threat.

Diseases caused by enterovirus infection (Cocksackie, Foot and Mouth Disease)

·                    Poliomyelitis primarily via the fecal-oral route

·                    Polio-like syndrome found in children who tested positive for enterovirus 68.[23][24]

·                    Nonspecific febrile illness is the most common presentation of enterovirus infection. Other than fever, symptoms include muscle pain, sore throat, gastrointestinal distress/abdominal discomfort, and headache. In newborns the picture may be that of sepsis however, and can be severe and life-threatening.

·                    Enteroviruses are by far the most common causes of aseptic meningitis in children. In the United States, enteroviruses are responsible for 30,000 to 50,000 meningitis hospitalizations per year as a result of 30 million to 50 million infections.[2]

·                    Bornholm disease or epidemic pleurodynia is characterized by severe paroxysmal pain in the chest and abdomen, along with fever, and sometimes nausea, headache, and emesis.

·                    Pericarditis and/or myocarditis are typically caused by enteroviruses; symptoms consist of fever with dyspnea and chest pain. Arrhythmias, heart failure, and myocardial infarction have also been reported.

·                    Acute hemorrhagic conjunctivitis can be caused by enteroviruses.

·                    Herpangina is caused by Coxsackie A virus, and causes a vesicular rash in the oral cavity and on the pharynx, along with high fever, sore throat, malaise, and often dysphagia, loss of appetite, back pain, and headache. It is also self-limiting, with symptoms typically ending in 3–4 days.

·                    Hand, foot and mouth disease is a childhood illness most commonly caused by infection by Coxsackie A virus or EV71.

·                    Encephalitis is rare manifestation of enterovirus infection; when it occurs, the most frequent enterovirus found to be causing it is echovirus 9.

·                    A 2007 study suggested that acute respiratory or gastrointestinal infections associated with enterovirus may be a factor in chronic fatigue syndrome.[25]

·                    Diabetes mellitus type 1 It has been proposed that type 1 diabetes is a virus-triggered autoimmune response in which the immune system attacks virus-infected cells along with the insulin-producing beta cells in the pancreas.[26] A team working at University of Tampere, Finland has identified a type of enterovirus that has a possible link to type 1 diabetes (which is an autoimmune disease).[27][28]



More on enteroviruses, possibly in ticks:


Are people getting foot and mouth disease from Plum Island-escaped ticks, too (Plum Island has always experimented with Hoof and Mouth disease)?  Imagine how sick people are with Lyme, if they have all these combined devastating illnesses?  Yet, we’re all trashed aren’t we?  Are we trashed because this is crime or are we trashed because we represent a bioweapons experiment (escaped ticks) gone horribly wrong?  Why is the CDC lying about all this?  For personal staff vaccines incomes reasons?  Has this scam gone on so long the CDC and NIH finds no way of backing away from all their lies?  Is the mortified at the prospect at having been discovered to 200% incompetent to their mission?  Now they’re selling “vaccines” that actually give people the very diseases the vaccines are intended to prevent?


It happened with the MMRs and it happened with LYMErix (giving people an immunosuppression disease).


THAT is your “Health and Human Services” or, being 200% incompetent to all major issues of every day life and health: Cancer, Chronic Fatiguing post-sepsis which by their own accounts, affects 12 million of us, excluding Lyme -, and easily half of all “autoimmune” diseases.


THAT is why our YouTube channel is “HHSonthecouch,”  They’re frickin mental.



Oh, and Allen Steere has never discovered how Lyme or OspA could cause arthritis in 42 years.  He’s still looking, though, in his “high security” T cell freezers. 

Yves Lobet at SmithKline said of Allen Steere’s “autoimmune bad knees” proposal (hLFA-1) at the FDA meeting in Jan 2001 on LYMErix adverse events, that if OspA created autoimmune response against something on an HLA antigen, then this phenomenon would be seen all throughout the body and not just in the knees.  He basically made fun of Steere.  Find that here: 




Restate the Charges:

Racketeering ( is a fake non-profit, just a commercial front),

Defrauding the Government with false claims for grants based on Dearborn,

Color of Law (slander and libel, denial of rights),

Assaulting children with a known fake vaccine just to see how bad would be the adverse events.


The fake toxin of a vaccine, Pam3Cys has always been known to be a toxin and never a vaccine. 


Thimerosal was put in vaccines to prevent LYMErix.



Demand a Senate hearing to refer to the USDOJ, mention that a lack of action on this will risk their “future electability,” and will “question the competency” of the Senator/Congressmen you’re lobbying.  Murder, permanent disability, denial of rights, slander, assaulting children … for profit is not acceptable.  Make sure this is clear.  Look them straight in the eye.  They work for you.  Literally, their JOB is to do YOUR bidding.




LOBBYISTS - what is required of you:


1) Lobbyists are expected to be the “best-of-the-best,” Navy Seals type Lyme warriors.  The goal is to put the criminals in prison.  

2) No lobbyist will be allowed to talk about themself, even if asked.  Personal experience is anecdote, not data.  Quit/Stop right here and go no further if you don’t understand what that means.

3) No lobbyist can object to the science we present here because none of the publications are ours. Everyone should their objections to the authors of the science we re-present.  


4) We only want top-shelf people: no cowards, no fairies, no effeminate types who think drama and personal experience counts for anything. They absolutely DO NOT.


No prosecutor gets up in front of a jury and judge and starts talking about his prostate problems while prosecuting a drugs charge.  He JUST SAYS and SHOWS what the bad guys did. The only kind of people we want are the ones with the balls to stick to the script and not insert themselves into the equation.  This is a CHARACTER issue, only.  Not a talent issue.  Tell the story of THE OTHERS.


You can volunteer to be a lobbyist for these causes (Lyme, Autism, CFIDS, ME/CFS, Fibro, etc.), but you must be trained as to what exactly needs to be prosecuted and can present it in 5 or 10 minutes.  

The goal is a Senate hearing for referral to the DOJ (think: this will go on CSPAN).  There are a lot of issues, but essentially, where CDC staff members committed fraud to either advance their own personal prestige or income agenda or BigPharma's, that's what we want prosecuted.  We use the CDC's own data to show what crimes they and their associates committed.

This Lyme Cryme story has never been properly re-told in any book or by any journalist, but the facts of what happened at Dearborn have been available to the public for over 20 years.  How Steere falsified the testing in Europe was available, what OspA is has been available since around 1999.  But not until 2005 did this author find its structure because it was not shown in any OspA patent. A triacyl-lipopeptide could never have been a vaccine if it is a fungal antigen (managed by TLRs 1 & 2).   Except for the scientists we quote (Latov, Marks, Harding, Medvedev, Persing, Schoen, etc on the “Occam’s Razor” report), no "doctor" has ever explained why LYMErix failed as a fungal antigen. 


Tthe most remarkable aspect of this crime of all:  Not one single person in the USA or Canada or even Europe that we know of, with "MD" after their names, has a clue what's going on and none ever ask. They don’t ask, they don’t wonder.  This tells you there is probably plenty more about which "MDs" are clueless and prefer to remain so.  [Turns out, OHYEAH, there's plenty in plain sight they’re not seeing (Humira, Stelara, MMR monograph warnings, there is no NIIID, ...)].

TAKE HOME POINT:  The Klempner "long-term” “treatment” study" became the basis of the Infectious Diseases Society of America's (IDSA's) "Guidelines" on the “diagnosis and treatment of Lyme disease.”  Here we will show the case definition (diagnosis criteria. “Dearborn,” 2-tiered) was falsified, and therefore there can be no guidelines on treatment or diagnosis.  If the “guidelines” are gone, insurance companies cannot deny care or testing payments.